Annual Meeting Accreditation Information

 

 

 

Target Audience
This activity is intended for physicians, nurses, nurse practitioners, healthcare executives, perfusionists, pharmacists and laboratory technicians engaged in the area of patient blood management.

Educational Objectives
After completing this activity, the participant should be better able to:

  • Utilize strategies to minimize all modalities of blood loss and enhance blood production.
  • Employ strategies to optimize coagulation to mitigate the risk of excessive blood loss or development of thrombosis.
  • Assess the latest research based recommendations for the detection, evaluation and treatment of anemia in hospitalized and non-hospitalized patients.
  • Explain the rationale for quality, safety and financial metrics for successful patient blood management programs.
  • Evaluate the elements of patient centered decision-making as it relates to patient blood management.
  • Discuss strategies to improve communication and collaboration among the healthcare team as it relates to patient blood management

 

Faculty/Meeting Chairs
Gee Mei Tan, MBBS, MMED
  • Children's Hospital Colorado, Aurora, CO
  • Associate Professor, Anesthesiology Department
  • Medical Director of Anesthesiology Preoperative Clinic
  • Chair of the Blood Utilization Review Team
Kellie Simmons-Massey, DNP, MSN, AP-C
  • Temple University Hospital, Philadelphia, PA
  • Director, Blood Management/Bloodless Medicine & Surgery

Additional faculty can be found on the meeting program available by clicking here.  

Joint Accreditation Statement

 

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and the Society for the Advancement of Blood Management. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
Live Sept. 10 – 12, 2020
The Postgraduate Institute for Medicine designates this live activity for a maximum of 17.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring: Sept. 11, 2020 – Sept 10, 2022
The Postgraduate Institute for Medicine designates the enduring activity for a maximum of 20.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Continuing Nursing Education
Live Sept. 10 – 12, 2020
The maximum number of hours awarded for this Continuing Nursing Education activity is 17.5 contact hours.Designated for 1.9 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.

Enduring: Sept. 11, 2020 – Sept 10, 2022
The maximum number of hours awarded for this Continuing Nursing Education activity is 20 contact hours. Designated for 1.9 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.

P.A.C.E.® Continuing Education
Live Sept. 10 – 12, 2020
P.A.C.E.® Accreditation Statement Postgraduate Institute for Medicine has been approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This program is approved for up to 17.5 ASCLS P.A.C.E. ® contact hours.  Sessions must be attended live to receive P.A.C.E. credit.

Perfusionist Continuing Education
Live Sept. 10 – 12, 2020
This activity has been approved by the American Board of Cardiovascular Perfusion for a maximum of 18.6 Category I CEUs.

  • Thursday, September 10 6.6
  • Friday, September 11, 7.8
  • Saturday, September 12 4.2
  • Total Possible 18.6 CEUs

Sessions must be attended live to receive ABCP credit.

American College of Healthcare Executives Education
Live Sept. 10 – 12, 2020
By attending the SABM 2020 Virtual Annual Meeting offered by the Society for the Advancement of Blood Management and the Postgraduate Institute for Medicine (PIM) participants may earn up to 17.5 ACHE Qualified Education Hours toward initial certification or recertification of the Fellow of the American College of Healthcare Executives (FACHE) designation.  Sessions must be attended live to receive ACHE credit.

Interprofessional Continuing Education

This activity was planned by and for the healthcare team, and learners will receive 17.5 Interprofessional Continuing Education (IPCE) credit for learning and change. 

 

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Please click here to view a Speaker Conflict of Interest Disclosure summary.

Planners and Managers
The PIM planners and managers have nothing to disclose. The Society for the Advancement of Blood Management planners and managers have nothing to disclose.

Media
This event will be offered through the vFairs Virtual Event Platform for the live sessions September 10-12, 2020 and will be offered through a learning management system and the vFairs Virtual Event Platform for the enduring credits.

Computer System Requirements
To participate in the education and activities a person will need a computer, tablet and/or smart phone that can connect to the internet.  The selected hardware (computer, tablet and/or smart phone) must have the ability to play the video and audio components of the program.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.